Lenire: New Tinnitus Treatment Available at CHC
- Dominique Calandrillo, AuD, CCC-A
- 23 hours ago
- 2 min read
Updated: 42 minutes ago
Dominique Calandrillo, AuD, CCC-A, Tinnitus Expert
With Lenire, 91% of participants experienced a reduction in tinnitus severity sustained for at least 12 months after treatment (2nd clinical trial).
For nearly 40 years, the Center for Hearing and Communication (CHC) has provided high-quality tinnitus and hyperacusis therapy, emphasizing a holistic, patient-centered model. Treatment therapies have included tinnitus retraining therapy (TRT), hearing aids tailored to your tinnitus experience, sound enrichment, and customized counseling to restore comfort and control over the perception of sound.
Lenire is an FDA-Approved Medical Device
Today, our suite of treatment options is expanding to include Lenire, a cutting edge, FDA-approved medical device designed to treat tinnitus through bimodal neuromodulation. This means it pairs gentle sound therapy through headphones with mild electrical stimulation to the tongue using a device called a Tonguetip.
91% Report Reduction in Symptoms
In clinical trials involving more than 600 participants, Lenire users reported significant relief. And in a second major study, 91% of participants experienced a reduction in tinnitus severity that was sustained for at least 12 months after treatment.
Request an Appointment
If you or someone you know is struggling with tinnitus, CHC’s Tinnitus and Hyperacusis Center is here to help. With the introduction of Lenire, we are proud to offer another powerful tool to support your journey toward relief, comfort, and improved quality of life.
About the Author
Dr. Calandrillo provides comprehensive audiological care (conducted in English or ASL) to adults and children of all hearing abilities. With a clinical background that includes private practice, hospital and ENT settings, Dr. Calandrillo, has extensive expertise in hearing evaluations and the latest digital hearing technology. She has a passion for research and evidence-based clinical practice and enjoys helping clients understand and advocate for their hearing health needs.
Dr. Calandrillo holds a Doctor of Audiology from Gallaudet University where she was recognized with the Excellence in Audiology Award. She received training in tinnitus retraining therapy (TRT) under founder Dr. Pawel Jastreboff and is a certified Lenire provider.